Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators - D'Huyvetter, M; Aerts, A; Xavier, C (Contrast Media Mol Imaging, 2012)
et al.